| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |